Prostate Cancer and Supplementation with Alpha-tocopherol and Beta-carotene: Incidence and Mortality in a Controlled Trial
 
   

Prostate Cancer and Supplementation with
Alpha-tocopherol and Beta-carotene:
Incidence and Mortality in a Controlled Trial

This section is compiled by Frank M. Painter, D.C.
Send all comments or additions to:
   Frankp@chiro.org
 
   

FROM:   J Natl Cancer Inst 1998 (Mar 18);   90 (6):   440446

Heinonen OP, Albanes D, Virtamo J, Taylor PR, Huttunen JK, Hartman AM,
Haapakoski J, Malila N, Rautalahti M, Ripatti S, Maenpaa H, Teerenhovi L,
Koss L, Virolainen M, Edwards BK

Department of Public Health,
University of Helsinki, Finland


BACKGROUND:   Epidemiologic studies have suggested that vitamin E and beta-carotene may each influence the development of prostate cancer. In the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study, a controlled trial, we studied the effect of alpha-tocopherol (a form of vitamin E) and beta-carotene supplementation, separately or together, on prostate cancer in male smokers.

METHODS:   A total of 29133 male smokers aged 50-69 years from southwestern Finland were randomly assigned to receive alpha-tocopherol (50 mg), beta-carotene (20 mg), both agents, or placebo daily for 5-8 years (median, 6.1 years). The supplementation effects were estimated by a proportional hazards model, and two-sided P values were calculated.

RESULTS:   We found 246 new cases of and 62 deaths from prostate cancer during the follow-up period. A 32% decrease (95% confidence interval [CI] = -47% to -12%) in the incidence of prostate cancer was observed among the subjects receiving alpha-tocopherol (n = 14564) compared with those not receiving it (n = 14569). The reduction was evident in clinical prostate cancer but not in latent cancer. Mortality from prostate cancer was 41% lower (95% CI = -65% to -1%) among men receiving alpha-tocopherol. Among subjects receiving beta-carotene (n = 14560), prostate cancer incidence was 23% higher (95% CI = -4%-59%) and mortality was 15% higher (95% CI = -30%-89%) compared with those not receiving it (n = 14573). Neither agent had any effect on the time interval between diagnosis and death.

CONCLUSIONS:   Long-term supplementation with alpha-tocopherol substantially reduced prostate cancer incidence and mortality in male smokers. Other controlled trials are required to confirm the findings.


Return to the VITAMIN E Page

Since 1-01-2005

         © 19952017 ~ The Chiropractic Resource Organization ~ All Rights Reserved